Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram effects on nocturnal light response
ACTRN12614000807651Phase 4Completed
- Sponsor
- Monash University
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of citalopram (2 arms), sponsored by Monash University. Primary endpoints: Salivary melatonin levels, Objective alertness and 1 more. Started Jun 2014; status: completed.
02
Drugs
citalopram
Beyond the preview
Go deeper on ACTRN12614000807651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000807651.